Surgical Site Infections: Definition, Epidemiology, and Management

Definition and Classification

• The American College of Surgeons defines surgical site infections (SSIs) as infections that occur within 30 days after surgery, involving the skin, subcutaneous tissue, or deeper tissues, with at least one of the following: purulent drainage, positive culture, signs of infection, or diagnosis by the attending physician 1, 2, 3
• SSIs are classified into three categories: superficial, deep, and organ/space, each with specific criteria for diagnosis 2, 3, 4

Epidemiology

• The incidence of SSIs is approximately 2.6%, accounting for 38% of nosocomial infections in surgical patients, according to the Centers for Disease Control and Prevention 1
• The risk of SSI varies depending on the surgical wound category, with clean wounds having a lower risk (1.5%) compared to clean-contaminated (7.7%), contaminated (15.2%), and dirty wounds (40%) 2, 3, 4, 5

Diagnosis

• The presence of purulent drainage is diagnostic of SSI, and clinical evaluation should include signs of inflammation, erythema, and induration, as recommended by the Infectious Diseases Society of America 1, 2, 3
• Microbiological studies, including cultures and Gram stains, should be performed to identify the causative pathogens, as suggested by the Clinical Infectious Diseases journal 2, 3, 6

Management

• The American College of Surgeons recommends surgical management, including incision and drainage, for SSIs, with adjuvant antibiotic therapy for cases with significant systemic response 1, 7
• Antibiotic selection should be based on the type of surgery, with coverage for methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA), as well as gram-negative and anaerobic bacteria, as recommended by the Infectious Diseases Society of America 1, 6

Special Considerations

• SSIs can lead to sepsis and bacteremia, particularly in deep and organ/space infections, and require prompt attention, as emphasized by the Critical Care Medicine journal 1, 3, 4
• Early detection and treatment of anaerobic infections are crucial, as they can be technically challenging to diagnose, as noted by the Intensive Care Medicine journal 5

Surgical Site Infection Classification

Anatomical Classification

• The American College of Surgeons recommends that superficial incisional infections involve only the subcutaneous space, between the skin and the underlying muscular fascia, and occur within 30 days after surgery 8
• Deep incisional infections involve the deep layers of soft tissue (fascia and muscle) in the incision, and occur within 30 days after surgery or up to one year if a prosthesis was inserted, with a higher mortality rate (13.2%) and need for reoperation (53.2%) compared to superficial infections 8, 9, 10
• Organ/space infections involve any part of the anatomy (organs or spaces) distinct from the opened incision during the operation, with the same time restrictions and evidence of infection as deep incisional infections, and are associated with a mortality rate of 5.7% and need for reoperation of 44.0% 8, 9, 10

Clinical Severity Classification

• The World Society of Emergency Surgery (WSES) recommends a classification system with four classes: Class 1 (systemically well patients), Class 2 (systemically ill patients with stable comorbidities), Class 3 (toxic-appearing patients), and Class 4 (patients with sepsis or potentially life-threatening infections) 11

Management According to Infection Type

• The Infectious Diseases Society of America recommends that superficial incisional infections be treated with conservative management using antibiotics in approximately 60% of cases, while deep incisional infections require antibiotics in all cases and 50% require surgical intervention 10
• Organ/space infections require antibiotics in 100% of cases, with approximately 68.2% requiring radiologic intervention for drainage, and treatment with broad-spectrum antibiotics (piperacillin-sulbactam, ciprofloxacin, or meropenem plus clindamycin or metronidazole) for necrotizing infections 10

Epidemiology and Burden

• The incidence of surgical site infections is approximately 2.6%, representing 38% of nosocomial infections in surgical patients, and increases morbidity, mortality, hospital stay, and hospital costs 8
• Any deep surgical site infection that does not resolve as expected after treatment should be investigated as a possible manifestation of a deeper organ/space infection 12

Guideline for Management of Surgical Site Infections Using the Southampton Scoring System

Post‑operative Wound Care (Grades 0‑Ic)

• Routine postoperative wound management without additional interventions is recommended for wounds classified as Grade 0 to Grade Ic. 13
• Dressings should be removed after a minimum of 48 hours unless there is evidence of wound leakage. 13
• Prophylactic antibiotics are not indicated for these low‑grade wounds. 14

Management of Grade II (Erythema with Inflammation)

• Prior to initiating antibiotics, clinicians should assess for systemic signs of infection (e.g., fever, tachycardia, leukocytosis). 14
• Systemic antibiotics are added when any of the following are present: erythema extending >5 cm from the wound edge, temperature >38.5 °C, heart rate >110 beats/min, or white‑blood‑cell count >12 000/µL. 14
• If erythema is isolated without systemic signs, close observation without antibiotics is advised. 14
• First‑generation cephalosporin or antistaphylococcal penicillin is recommended for MSSA coverage in Grade II infections. 14
• When MRSA risk factors exist (e.g., nasal colonization, prior MRSA infection, recent hospitalization, recent antibiotic exposure), coverage should be expanded to include vancomycin, linezolid, or daptomycin. 14

Management of Grades IIIa‑IIIb (Serous or Serosanguinous Discharge)

• An open wound approach is indicated if the discharge is copious or accompanied by systemic inflammatory signs. 14
• Gram stain and culture should be obtained before starting antibiotics. 14
• Antibiotics are not routinely required when the wound is adequately drained and the patient lacks systemic signs. 14
• Antibiotic therapy should be initiated only when temperature >38.5 °C, heart rate >110 beats/min, or erythema >5 cm beyond wound margins is observed. 14

Management of Grade IV (Purulent Discharge)

• Immediate surgical opening and drainage constitute the primary treatment for purulent infections. 14
• Gram stain and culture must be performed prior to antibiotic administration. 14
• A brief systemic antibiotic course (24–48 hours) is added only if systemic signs are present. 14
• For clean operative sites (trunk, head/neck, extremities), a first‑generation cephalosporin or antistaphylococcal penicillin is appropriate. 14
• For procedures involving the axilla, gastrointestinal tract, perineum, or female genital tract, additional gram‑negative and anaerobic coverage (e.g., cephalosporin or fluoroquinolone + metronidazole) is required. 14

Management of Grade V (Deep or Severe Infection)

• Immediate surgical consultation for extensive debridement and drainage is mandatory. 14
• Broad‑spectrum intravenous antibiotics are required, encompassing MRSA agents (vancomycin, linezolid, or daptomycin) plus gram‑negative and anaerobic coverage (piperacillin‑tazobactam or a carbapenem). 14
• The duration of antibiotic therapy should be individualized and may be prolonged based on clinical response. 14

Critical Pitfalls to Avoid

• Relying solely on antibiotics without surgical drainage for purulent infections (Grades IV‑V) leads to high rates of treatment failure. 14
• Continuing antibiotics beyond 48 hours after clinical improvement following adequate drainage is discouraged. 14
• Advanced dressings do not reduce SSI rates compared with standard dressings for primarily closed surgical wounds. 13
• Surgical site infections are uncommon within the first 48 hours post‑operation; fever during this period is usually non‑infectious unless caused by streptococcal or clostridial pathogens. 14

Surgical Site Infection – Evidence‑Based Diagnosis and Management

Definition and Diagnostic Criteria

• A postoperative wound is classified as a surgical site infection (SSI) when it occurs within 30 days of the operation (or up to 1 year when an implant is placed) and meets depth‑specific criteria (superficial, deep incisional, or organ/space). 15
• Superficial incisional SSI involves only the skin and subcutaneous tissue above the fascia. 15
• Deep incisional SSI involves the fascia and muscle layers and requires evidence of purulence, wound dehiscence, an abscess identified on re‑operation or imaging, or a clinical diagnosis by the surgeon. 16
• Organ/space SSI involves any anatomical space opened during the procedure (excluding the incision) and follows the same time frame as deep incisional SSI. 16
• SSIs rarely present within the first 48 hours after surgery; fever in this early period is usually non‑infectious unless caused by Streptococcus pyogenes or Clostridium species. 15

Assessment of Systemic Inflammatory Response

• Systemic inflammatory response criteria (SIRS) guide the decision to add antibiotics: erythema/induration extending >5 cm from the wound edge, temperature >38.5 °C, heart rate >110 beats/min, or white‑blood‑cell count >12 000 cells/µL. Presence of any criterion indicates the need for antimicrobial therapy. [15][17]

Primary Surgical Management

• The cornerstone of SSI treatment is prompt suture removal and wide incision‑and‑drainage (I&D); this should be performed before any antimicrobial agents are started. [15][17]
• During I&D, the wound is opened widely, all purulent material is evacuated, and a dry sterile dressing is applied (avoid gauze packing, which increases pain without improving healing). [15][17]

Indications for Antibiotic Therapy

• Antibiotics are NOT required after adequate drainage of a superficial SSI when no systemic inflammatory response is present. [15][17]
• Antibiotics ARE required when any SIRS criterion is met, in immunocompromised patients, or when signs of organ failure (hypotension, oliguria, altered mental status) are evident. [15][17]18

Empiric Antibiotic Selection

Clean Operations (trunk, head/neck, extremities)

• The predominant pathogens are staphylococci; coverage should target MSSA unless MRSA risk factors are present. [15][17]18
• Standard (MSSA) regimen: a first‑generation cephalosporin (e.g., cefazolin) or an antistaphylococcal penicillin (e.g., nafcillin, oxacillin). [15][17]
• High MRSA‑risk patients (risk factors: recent hospitalization, recent β‑lactam/quinolone exposure, age ≥ 75 years, residence in a long‑term‑care facility, Charlson comorbidity index > 5, or current hospitalization > 16 days) should receive MRSA‑active agents. 18
• MRSA‑active agents: vancomycin (first‑line) and, when vancomycin is unsuitable, telavancin. [15][17]

Contaminated/Dirty Operations (axilla, gastrointestinal tract, perineum, female genital tract)

• Empiric therapy must cover gram‑negative bacilli and anaerobes in addition to staphylococci. [15][17]18
• Standard regimen: a cephalosporin plus metronidazole or a fluoroquinolone plus metronidazole. [15][17]

Beta‑Lactam Allergy Alternatives

• For patients with a true type I hypersensitivity to β‑lactams, non‑β‑lactam regimens are recommended.
• MSSA coverage: clindamycin (300–450 mg q6–8 h) or vancomycin pending culture results. [15][17]
• Gram‑negative/anaerobic coverage: a fluoroquinolone (ciprofloxacin or levofloxacin) plus metronidazole. [15][17]

Duration of Antimicrobial Therapy

• Antibiotic courses should be brief and driven by clinical response rather than fixed durations. 15
• After adequate drainage, antimicrobials are continued only until systemic signs resolve (generally 24–48 hours). 15

Microbiologic Considerations

• Polymicrobial infections are common in contaminated or dirty surgical procedures. 15
• Blood cultures have limited diagnostic yield for superficial SSI but are recommended for deep incisional or organ/space infections. 16

Criteria and Epidemiology of Surgical Site Infections

Time‑Based Criteria

• Surgical site infections (SSIs) are defined as infections occurring within 30 days after any operative procedure in patients without implanted material. 19
• When a prosthetic device or implant is placed, the SSI surveillance period is extended to up to 1 year after the operation. 19

Anatomical Classification and Diagnostic Requirements

• Superficial incisional SSI – infection limited to skin and subcutaneous tissue above the fascia; diagnosis requires at least one of: purulent drainage, positive culture from aseptically obtained fluid, local signs of infection (pain, tenderness, swelling, redness, heat), or surgeon’s clinical diagnosis. 19
• Deep incisional SSI – infection involving fascia and muscle layers beneath the superficial incision; diagnosis requires at least one of: purulent drainage from the deep incision, spontaneous or surgeon‑opened wound dehiscence with fever or localized pain, abscess identified on re‑operation or imaging (ultrasound/CT), or surgeon’s clinical diagnosis. 19
• Organ/space SSI – infection of any anatomical space or organ opened or manipulated during the procedure (excluding the incision); diagnosis requires at least one of: purulent drainage from a drain placed in the organ/space, positive culture from aseptically obtained fluid, abscess identified on re‑operation or imaging, or surgeon’s clinical diagnosis. 19

Critical Diagnostic Pitfalls

• Early postoperative fever (first 48 hours) is rarely indicative of an SSI unless caused by highly virulent organisms (e.g., β‑hemolytic streptococci, Clostridium spp.); the majority of SSIs present between postoperative days 4–6. 19
• Purulent drainage alone is sufficient to diagnose an SSI and does not require microbiologic confirmation before initiating treatment. 19
• Wound dehiscence with fascial separation automatically qualifies as a deep incisional SSI, irrespective of other criteria. 19

Relationship to Wound Classification (Infection Risk by Contamination Level)